VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
BEAM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
BEAMBeam Therapeutics Inc.
$26.41$2.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksBEAMQuarterly Financials

Beam Therapeutics Inc. (BEAM) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Beam Therapeutics Inc. (BEAM) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

BEAM Income Statement

Quarterly statement

BEAM Income Statement

Beam Therapeutics Inc. (BEAM) annual income statement — 9-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue307K490K31.74M114.11M9.7M8.47M7.47M30.07M14.27M11.77M7.41M316.19M17.19M20.12M24.21M20.04M15.8M16.65M8.43M51.07M
Revenue Growth %-96.83%-94.21%324.87%279.52%-32.03%-28.08%0.81%-90.49%-17.01%-41.48%-69.39%1478.04%8.82%20.8%187.1%-60.76%1970.64%---
Cost of Goods Sold000000000084.82M140.08M100.05M97.61M99.65M86.34M85.29M74.56M65.41M-58.17M
COGS % of Revenue----------1144.64%44.3%581.92%485.23%411.62%430.91%539.83%447.73%775.74%-113.91%
Gross Profit307K490K31.74M114.11M9.7M8.47M7.47M30.07M14.27M11.77M-77.41M176.12M-82.86M-77.49M-75.44M-66.3M-69.49M-57.9M-56.98M109.24M
Gross Margin %100%100%100%100%100%100%100%100%100%100%-1044.64%55.7%-481.92%-385.23%-311.62%-330.91%-439.83%-347.73%-675.74%213.91%
Gross Profit Growth %-96.83%-94.21%324.87%279.52%-32.03%-28.08%109.65%-82.93%117.22%115.19%-2.61%365.62%-19.24%-33.83%-32.4%-160.7%-29.02%-27.06%70.03%436.7%
Operating Expenses141.63M127.04M138.95M131.55M136.51M128.62M126.76M130.1M120.77M116.67M26.72M43.26M25.41M24.66M23.49M22.68M21.82M24.06M19.25M172.72M
OpEx % of Revenue46133.22%25927.14%437.81%115.29%1407.6%1519.22%1696.87%432.71%846.4%991.06%360.65%13.68%147.79%122.57%97.03%113.2%138.08%144.5%228.26%338.22%
Selling, General & Admin31.52M31.95M34.43M32.28M26.74M26.86M27.94M28.66M26.52M29.63M26.72M43.26M25.41M24.66M23.49M22.68M21.82M24.06M19.25M17.77M
SG&A % of Revenue10266.78%6519.8%108.48%28.29%275.73%317.26%374.03%95.32%185.82%251.66%360.65%13.68%147.79%122.57%97.03%113.2%138.08%144.5%228.26%34.8%
Research & Development110.11M95.1M104.52M99.28M109.77M101.76M98.82M101.44M94.26M87.04M84.82M140.08M100.05M97.61M99.65M86.34M85.29M74.56M65.41M96.78M
R&D % of Revenue35866.45%19407.35%329.33%87%1131.87%1201.96%1322.84%337.39%660.58%739.39%1144.64%44.3%581.92%485.23%411.62%430.91%539.83%447.73%775.74%189.51%
Other Operating Expenses0000000000-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K1000K
Operating Income-141.32M-126.55M-107.22M-17.45M-126.81M-120.15M-119.29M-100.04M-106.5M-104.89M-104.13M132.86M-108.27M-102.15M-98.93M-88.98M-91.3M-81.97M-76.22M-63.48M
Operating Margin %-46033.22%-25827.14%-337.81%-15.29%-1307.6%-1419.22%-1596.87%-332.71%-746.4%-891.06%-1405.29%42.02%-629.72%-507.79%-408.66%-444.1%-577.9%-492.23%-904%-124.31%
Operating Income Growth %-11.44%-5.33%10.12%82.56%-19.07%-14.54%-14.55%-175.3%1.63%-2.69%-5.26%249.3%-18.58%-24.62%-29.78%-40.17%-31.12%-38.99%61.96%-55.6%
EBITDA-135.88M-121.14M-101.61M-11.78M-121.25M-114.61M-113.76M-94.59M-101.03M-99.32M-98.7M138.22M-103.08M-97.33M-94.28M-85.04M-87.83M-78.55M-72.91M-60.85M
EBITDA Margin %-44259.61%-24723.06%-320.15%-10.32%-1250.27%-1353.8%-1522.86%-314.61%-708.03%-843.69%-1332%43.71%-599.55%-483.85%-389.46%-424.42%-555.92%-471.7%-864.72%-119.15%
EBITDA Growth %-12.06%-5.7%10.68%87.55%-20.02%-15.4%-15.26%-168.44%1.99%-2.04%-4.69%262.53%-17.36%-23.91%-29.31%-39.76%-29.38%-37.07%63.36%-53.95%
D&A (Non-Cash Add-back)5.45M5.41M5.61M5.67M5.56M5.54M5.53M5.44M5.47M5.58M5.43M5.36M5.19M4.82M4.65M3.94M3.47M3.42M3.31M2.63M
EBIT-134.41M-122.68M-94.32M244.3M-112.73M-102.29M-109.27M-90.35M-96.67M-91.01M-98.67M132.86M-108.27M-102.15M-98.93M-88.98M-91.3M-81.97M-76.22M91.47M
Net Interest Income6.09M09.87M10.64M10.9M12.33M9.86M10.93M12.13M14.19M11.85M12.06M12.7M11.95M9.96M7.61M4.98M2.06M644K54K
Interest Income6.09M09.87M10.64M10.9M12.33M9.86M10.93M12.13M14.19M11.85M12.06M12.7M11.95M9.96M7.61M4.98M2.06M644K54K
Interest Expense00000000000000000--0
Other Income/Expense6.92M3.88M12.9M261.74M14.08M17.86M10.02M9.68M9.84M13.88M5.46M11.3M12.18M19.37M2.47M51.64M-15.86M10.02M7.01M-1.22M
Pretax Income-134.41M-122.68M-94.32M244.3M-112.73M-102.29M-109.27M-90.35M-96.67M-91.01M-98.67M144.16M-96.09M-82.78M-96.46M-37.35M-107.17M-71.95M-69.21M-64.71M
Pretax Margin %-43780.13%-25036.33%-297.18%214.09%-1162.38%-1208.26%-1462.78%-300.51%-677.47%-773.12%-1331.57%45.59%-558.88%-411.49%-398.46%-186.4%-678.3%-432.08%-820.85%-126.7%
Income Tax00000000039K01.37M0001M2.41M000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%-0.04%0%0.95%0%0%0%-2.68%-2.25%0%0%0%
Net Income-134.41M-122.68M-94.32M244.3M-112.73M-102.29M-109.27M-90.35M-96.67M-91.05M-98.67M142.8M-96.09M-82.78M-96.46M-38.35M-109.58M-71.95M-69.21M-64.71M
Net Margin %-43780.13%-25036.33%-297.18%214.09%-1162.38%-1208.26%-1462.78%-300.51%-677.47%-773.45%-1331.57%45.16%-558.88%-411.49%-398.46%-191.39%-693.56%-432.08%-820.85%-126.7%
Net Income Growth %-19.23%-19.93%13.68%370.38%-16.61%-12.34%-10.74%-163.27%-0.6%-10%-2.29%472.36%12.31%-15.05%-39.36%40.73%-289.7%5.64%65.66%32.22%
Net Income (Continuing)-134.41M-122.68M-94.32M244.3M-112.73M-102.29M-109.27M-90.35M-96.67M-91.05M-98.67M142.8M-96.09M-82.78M-96.46M-38.35M-109.58M-71.95M-69.21M-64.71M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.28-1.18-0.912.33-1.10-1.00-1.24-1.10-1.17-1.11-1.211.73-1.22-1.08-1.16-0.54-1.56-0.69-0.80-0.95
EPS Growth %-16.36%-18%26.61%312.26%5.98%9.91%-2.48%-163.45%4.1%-2.78%-4.31%420.37%21.79%-56.52%-45%43.16%-271.43%43.9%76.12%40.25%
EPS (Basic)-1.28-1.18-0.912.37-1.10-1.00-1.24-1.10-1.17-1.11-1.211.77-1.22-1.08-1.16-0.54-1.56-0.69-0.80-0.95
Diluted Shares Outstanding104.7M104.33M103.26M104.93M102.57M102M87.98M82.31M82.41M82.31M81.7M82.7M79.02M76.34M72.27M70.78M70.34M70.21M68.7M67.99M
Basic Shares Outstanding104.7M104.33M103.26M102.88M102.57M102M87.98M82.31M82.41M82.31M81.7M80.86M79.02M76.34M72.27M70.78M70.34M70.21M68.7M67.99M
Dividend Payout Ratio--------------------